Economy
Dr. Reddy's and Takeda Partner to Distribute QDENGA Vaccine in India
The Hindu57m
THE BRIEF
1
Dr. Reddy's Laboratories signed an exclusive distribution agreement with Takeda Pharmaceutical Company on Friday to market India's first approved dengue vaccine, QDENGA, in the private market.
2
Subject to local regulatory processes, the live-attenuated tetravalent vaccine is expected to become available in the first half of 2027 for pediatric and adult vaccination.
3
Dr. Reddy's will handle private-market distribution and physician engagement, while Takeda retains public market rights, legal ownership, and brand oversight.